Sangamo Therapeutics
OTC SGMOQ · Richmond, CA
Works in Cardiovascular · Dermatology · Genetic & rare · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Psychiatry · Renal & urogenital · Women's health
Sangamo Therapeutics is a clinical trial sponsor based in Richmond, CA, listed as OTC SGMOQ. It has 4 active clinical trials with 78 planned participants, across 11 therapeutic areas. Since 2021 it has completed 10 trials and stopped 5 early.
Trial track record · since 2021
Financials · OTC SGMOQ
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Sangamo Therapeutics
Sangamo Therapeutics is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 78 planned participants, in Cardiovascular, Dermatology, Genetic & rare, Hematology and other areas. Since 2021 it has completed 10 trials and stopped 5 early.
Sangamo Therapeutics is based in Richmond, CA and is listed as OTC SGMOQ. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sangamo Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-20.
Approve Suite is not affiliated with Sangamo Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.